Form D · Biotechnology

Modulate Bio Inc.

Allston, MA · CIK 0002026915

Offering snapshot reported Apr 7, 2026 · SEC filing

Reported sold
$785K
Offering amount: $1M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 11, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$393K$785KJun 13, 2024: $200,000.00Jun 13, 2024Jun 12, 2025: $660,000.00Jun 12, 2025Apr 7, 2026: $785,320.00Apr 7, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$660,000 → $785,320
  • Reported investors8 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 7, 2026Amendment$785,320$125,320vs Jun 12, 202510SEC filing
Jun 12, 2025Amendment$660,000$460,000vs Jun 13, 20248SEC filing
Jun 13, 2024Initial$200,000No comparison2SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-515949

Source: Form D, filed Apr 7, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mitchell Buckley Executive, Promoter
Dario Doller Director, Executive, Promoter
Kevin Hodgetts Promoter
Andrew Thomson Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Pagliuca Harvard Life Lab 127 Western Ave
Allston, MA, 02134